Skip to main content

Research Repository

Advanced Search

All Outputs (10)

A Primary Care Audit of Fracture Risk Management in Patients with a History of Chronic Pancreatitis (2020)
Presentation / Conference
Cottrell, E., Edwards, J., & Paskins, Z. (2020, August). A Primary Care Audit of Fracture Risk Management in Patients with a History of Chronic Pancreatitis. Poster presented at World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020)

Objective: To establish whether patients with a history of chronic pancreatitis have had appropriate fracture risk assessment. Methods: This audit was undertaken in a research ready, teaching practice with a list size of 11,377 on 18 November 2019... Read More about A Primary Care Audit of Fracture Risk Management in Patients with a History of Chronic Pancreatitis.

SUMMING UP : CHALLENGES AND OPPORTUNITIES FOR BETTER INTEGRATION OF PRIMARY AND SECONDARY CARE (2020)
Presentation / Conference
Paskins, Z. (2020, August). SUMMING UP : CHALLENGES AND OPPORTUNITIES FOR BETTER INTEGRATION OF PRIMARY AND SECONDARY CARE. Poster presented at World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020), Virtual

The implications for clinical practice and future research will be set, incorporating findings from the previous sessions.

TARGETING COMMUNICATION IN THE CLINICIAN-PATIENT CONSULTATION TO IMPROVE UPTAKE OF FRACTURE PREVENTION TREATMENTS: EARLY FINDINGS FROM THE IFRAP STUDY (2020)
Presentation / Conference
Paskins, Z. (2020, August). TARGETING COMMUNICATION IN THE CLINICIAN-PATIENT CONSULTATION TO IMPROVE UPTAKE OF FRACTURE PREVENTION TREATMENTS: EARLY FINDINGS FROM THE IFRAP STUDY. Poster presented at World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020), Virtual

iFraP is a 5-year study to design and test an intervention including a computerised decision aid, to use in the consultation, to promote informed decision making and informed adherence of osteoporosis drugs. Early findings from the iFraP study will b... Read More about TARGETING COMMUNICATION IN THE CLINICIAN-PATIENT CONSULTATION TO IMPROVE UPTAKE OF FRACTURE PREVENTION TREATMENTS: EARLY FINDINGS FROM THE IFRAP STUDY.

RECOMMENDATIONS TO IMPROVE QUALITY OF PATIENT INFORMATION MATERIALS IN OSTEOPOROSIS: RESULTS FROM A QUALITATIVE STUDY AND STAKEHOLDER CONSULTATION (2020)
Presentation / Conference
Greenall, C., Manning, F., Bullock, L., Hawarden, A., Leyland, S., Protheroe, J., …Jinks, C. (2020, August). RECOMMENDATIONS TO IMPROVE QUALITY OF PATIENT INFORMATION MATERIALS IN OSTEOPOROSIS: RESULTS FROM A QUALITATIVE STUDY AND STAKEHOLDER CONSULTATION. Poster presented at 34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Prague Congress Centre, Prague, Czech Republic

Objective: To identify inaccuracies, and contradictory statements in webbased patient information relating to osteoporosis and to produce recommendations for improvements. Methods: Nine commonly accessed patient information websites were selected f... Read More about RECOMMENDATIONS TO IMPROVE QUALITY OF PATIENT INFORMATION MATERIALS IN OSTEOPOROSIS: RESULTS FROM A QUALITATIVE STUDY AND STAKEHOLDER CONSULTATION.

IMPROVING COMMUNICATION OF FRACTURE RISK GLOBALLY: INSIGHTS FROM INTERVIEWS WITH PATIENTS. THE RISKCOMMUNICATION STUDY OR RICO STUDY (2020)
Presentation / Conference
Beaudart, C., Silverman, S., Paskins, Z., Boonen, A., Kaux, J., Fujiwara, S., & Hiligsmann, M. (2020, April). IMPROVING COMMUNICATION OF FRACTURE RISK GLOBALLY: INSIGHTS FROM INTERVIEWS WITH PATIENTS. THE RISKCOMMUNICATION STUDY OR RICO STUDY. Poster presented at World congress on osteoporosis, osteoarthritis and musculoskeletal diseases (WCO-IOF-ESCEO 2021)

Objective: Lack of or low quality communication between patient and healthcare provider may partially explain poor initiation and adherence to anti-osteoporosis treatment. In this study, we aimed to gain insights into patients’ understanding and pref... Read More about IMPROVING COMMUNICATION OF FRACTURE RISK GLOBALLY: INSIGHTS FROM INTERVIEWS WITH PATIENTS. THE RISKCOMMUNICATION STUDY OR RICO STUDY.

O04 Clinical and cost-effectiveness of ultrasound-guided intra-articular corticosteroid and local anaesthetic injection for hip OA: a randomised controlled trial (HIT) (2020)
Presentation / Conference
Paskins, Z., Bromley, K., Lewis, M., Hughes, G., Hughes, E., Cherrington, A., …Roddy, E. (2020, April). O04 Clinical and cost-effectiveness of ultrasound-guided intra-articular corticosteroid and local anaesthetic injection for hip OA: a randomised controlled trial (HIT). Presented at British Society for Rheumatology Annual Conference 2020, Glasgow, Scotland, UK

Background Evidence of the effectiveness of intra-articular corticosteroid injection for hip osteoarthritis (OA) is limited. The HIT trial compared the clinical and cost-effectiveness of an ultrasound-guided intra-articular hip injection (USGI) of 4... Read More about O04 Clinical and cost-effectiveness of ultrasound-guided intra-articular corticosteroid and local anaesthetic injection for hip OA: a randomised controlled trial (HIT).

EXPERIENCES OF DELIVERING A NURSE-LED FRACTURE RISK ASSESSMENT FOR PATIENTS WITH INFLAMMATORY RHEUMATOLOGICAL CONDITIONS IN PRIMARY CARE (2020)
Presentation / Conference
Hawarden, A. W., Paskins, Z., Ediriweera Desilva, E., Herron, D., Machin, A., Jinks, C., …Chew-Graham, C. (2020, April). EXPERIENCES OF DELIVERING A NURSE-LED FRACTURE RISK ASSESSMENT FOR PATIENTS WITH INFLAMMATORY RHEUMATOLOGICAL CONDITIONS IN PRIMARY CARE. Poster presented at British Society for Rheumatology Annual Conference 2020, Glasgow, Scotland, UK

Background The INCLUDE (INtegrating and improving Care for patients with infLammatory rheUmatological DisordErs in the community) pilot trial aimed to evaluate the feasibility and acceptability of a nurse-delivered review in primary care for people... Read More about EXPERIENCES OF DELIVERING A NURSE-LED FRACTURE RISK ASSESSMENT FOR PATIENTS WITH INFLAMMATORY RHEUMATOLOGICAL CONDITIONS IN PRIMARY CARE.